
Pneumonia Vaccine Research Study
Pneumonia represents a serious health risk for those with compromised immune systems including infants and the elderly. Vaccinated immunity may help those vulnerable. Advancing vaccine options is vital and is only possible with carefully conducted research studies.
Accellacare is enrolling a research study that is evaluating an investigational pneumonia vaccine for health adults ages 65 and older. Eligible participants will receive study-related care and study vaccine at no cost. Financial compensation up to $850 will also be provided for time and travel expenses.
Submit to learn more:
Please note: You may or may not benefit medically from taking part and you are able to opt out at anytime and do not have to give us a reason for doing so. Your primary care physician will be informed about your participation and all medical assessments that will be carried out as part of the study. If during screening any abnormal results are found your primary care physician will also be informed.